COHS Pilot Study Awards: Improving Human Health and Well-Being

Awardees

UCI Health Affairs funds innovative research projects through a series of multidisciplinary awards supporting basic, translational, clinical and population health projects. 

The UCI Susan & Henry Samueli College of Health Sciences (COHS) Pilot Studies award is designed to support pilot work from faculty in the COHS with a high potential to lead to improved human health and well-being at the clinical or public health level. 

Please see below for more information about the award winners and abstracts for each project.

Implementation of an Intensive Post-Discharge GDMT Optimization Pilot in Heart Failure

Collaborating Units: School of Medicine and School of Pharmacy & Pharmaceutical Sciences

Christine Cadiz, PharmD

Principal Investigator
Health Sciences Clinical Associate Professor, School of Pharmacy & Pharmaceutical Sciences

Dawn Lombardo, DO

Co-Investigator
Professor, Medicine; Medical Director, Heart Failure Program and Vice Chair of Education, School of Medicine

Joanne Wong, PharmD

Co-Investigator
Transitions of Care Pharmacist, Department of Pharmacy, UCI Health

Read Abstract

Despite a substantial body of evidence demonstrating the benefits of guideline directed medical therapy (GDMT) in patients with heart failure, GDMT use remains largely suboptimal. Timely and consistent follow-up care after heart failure hospitalization is needed to improve GDMT utilization to improve outcomes of mortality, hospitalization and functional capacity. This project will establish an intensive multidisciplinary post-discharge GDMT optimization program. The program will use remote monitoring to assist with assessment of clinical status, combined with a fast-paced weekly visit approach to achieve target or maximally tolerated GDMT early after hospital discharge.

Augmentation of Dynamin-1 Levels Using Catalpol to Prevent Cancer-related Cognitive Impairment (ADC Study)

Collaborating Units: School of Medicine and School of Pharmacy & Pharmaceutical Sciences

Alexandre Chan, PharmD, MPH

Principal Investigator
Professor of Clinical Pharmacy and Founding Chair, Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences

Munjal Acharya, PhD

Co-Investigator
Associate Professor, Anatomy & Neurobiology, School of Medicine

Read Abstract

Cancer-related cognitive impairment (CRCI) is highly prevalent in up to 75% of cancer survivors. Catalpol is a compound found in the roots of a plant called Rehmannia glutinosa. It has been shown to improve cognitive function in animal models and simultaneously increase the expression of dynamin-1 in the cerebral cortex and hippocampus. In the ADC study, we aim to determine the neuroprotective effects by enhancing neuronal dynamin-1 using catalpol in vivo to manage CRCI, with the aim to evaluate the therapeutic role of catalpol in mitigating CRCI following chemo- or radiation-therapy exposures.

Understanding Well-Being in Asian-American Prostate Cancer Survivors

Collaborating Units: Program in Public Health and School of Medicine

Michael Hoyt, PhD

Principal Investigator
Professor, Population Health and Disease Prevention, Public Health

Jacqueline Kim, PhD

Co-Investigator
Assistant Professor In Residence, Medicine, School of Medicine

David Lee, MD

Co-Investigator
Professor, Clinical Urology, Department of Urology

Read Abstract

Asian American communities comprise a sizable portion of our cancer treatment catchment area at UCI, yet little is known about their experiences, preferences, care needs and relationship impacts after prostate cancer. As UCI is emerging as a leader in behavioral oncology research with Asian American populations, this study will utilize qualitative methods and recruit Asian American prostate cancer survivors to gain in-depth understanding of changes in and influences on well-being, relationship dynamics and support, self-image and resilience factors, cancer-related physical changes, and supportive care needs. Findings have the potential to assist Asian American prostate cancer survivors in capitalizing on culturally-shaped resilience factors and mitigating risk factors to improve outcomes and to assist healthcare providers in providing culturally competent care.

Leveraging Mammography for Cardiovascular Disease Risk Assessment

Collaborating Units: Donald Bren School of Information and Computer Sciences, School of Medicine and Susan Samueli Integrative Health Institute

Sabee Molloi, PhD

Principal Investigator
Professor & Vice Chairman of Research, Radiological Sciences, School of Medicine

Peter Chang, MD

Co-Investigator
Assistant Professor In-Residence, Radiological Sciences & Pathology, School of Medicine; Co-Director, Center for Artificial Intelligence in Diagnostic Medicine; Co-Director, Precision Health through Artificial Intelligence; Assistant Professor In-Residence, Donald Bren School of Information and Computer Sciences

Shaista Malik, MD, PhD

Co-Investigator
Professor, School of Medicine; Associate Vice Chancellor, College of Health Sciences; Executive Director, Susan Samueli Integrative Health Institute

Craig Wilsen, MD, PhD

Co-Investigator
Assistant Clinical Professor, Radiological Sciences, School of Medicine

Zhaoxia Yu, PhD

Co-Investigator
Professor & Vice Chair for Undergraduate Studies, Statistics, Donald Bren School of Information and Computer Sciences

Read Abstract

Mammograms, essential for breast cancer screening starting at age 40, have the potential to take on a novel and significant role in assessing heart health. Traditionally, certain findings on mammograms, such as breast arterial calcifications, were not considered relevant to breast cancer risk and thus were not utilized for diagnostic purposes. This study aims to develop an automated technique for detecting breast arterial calcifications and will utilize a dataset from a diverse group of American women (n=5,059) to investigate its prevalence across different ethnicities. By integrating assessments of breast arterial calcification and breast density into routine mammograms, it may be possible to detect potential heart issues early, offering valuable insights beyond conventional assessments, all without additional radiation exposure or costs.

Analgesic Response to Opioids in Patients with Fibromyalgia after Traditional Acupuncture Versus Sham Acupuncture

Collaborating Units: School of Medicine and Susan Samueli Integrative Health Institute

Ariana Nelson, MD

Principal Investigator
Associate Professor, Anesthesiology, School of Medicine

Kevin Beier, PhD

Co-Investigator
Assistant Professor, Physiology & Biophysics, School of Medicine

Richard Harris, PhD

Co-Investigator
Professor, Anesthesiology and Perioperative Care, School of Medicine; Samueli Endowed Chair, Susan Samueli Integrative Health Institute

Read Abstract

This project addresses the inadequacy of pain management therapies available to patients with fibromyalgia, particularly those who experience hyperalgesia and diminished response to traditional opioid therapy. This disparity disproportionately affects women, as they are more likely to develop fibromyalgia.

Single Cell/Nucleus Analyses of Paired FSHD Biopsy Samples

Collaborating Units: School of Biological Sciences, School of Medicine and School of Pharmacy & Pharmaceutical Sciences

Kyoko Yokomori, PhD

Principal Investigator
Professor, Biological Chemistry, School of Medicine

Ali Mortazavi, PhD

Co-Investigator
Professor, Developmental & Cell Biology, School of Biological Sciences

Tahseen Mozaffar, MD

Co-Investigator
Professor, Neurology, School of Medicine

Xiangmin Xu, PhD

Co-Investigator
Chancellor’s Professor, Anatomy & Neurobiology, School of Medicine

Read Abstract

Facioscapulohumeral dystrophy (FSHD) is one of the most common muscular dystrophies with no cure, and its pathogenic process is still not completely understood. By combining high-throughput high-resolution spatial and single nucleus transcriptomics analyses, this project aims to establish a powerful strategy to determine disease-specific gene network alteration and contributions of other cell types in different muscles using needle biopsy samples with the goal of better stratifying the disease states of muscles and identifying a simplified minimum set of marker genes that may be cost-effectively used for monitoring disease progress and clinical trial effectiveness.